HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dietzman, R. H. Articles by Berger, E. C. Search for Related Content PubMed PubMed Citation Articles by Dietzman, R. H. Articles by Berger, E. C.

The Journal of Thoracic and Cardiovascular Surgery, Vol 69, 870-873, Copyright © 1975 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

The use of methylprednisolone during cardiopulmonary bypass. A review of 427 cases

RH Dietzman, JB Lunseth, B Goott and EC Berger

A study was designed to evaluate the hemodynamic effects of massive doses of methylprednisolone (30 mg. per kilogram) during cardiopulmonary bypass at normothermia and hypothermia. In 427 patients studied, significantly less vasoconstriction (p less than 0.01) and improved perfusion flows (p less than 0.0005) were obtained at comparable pressure levels in the steroid-treated group (272 patients) compared with the control group (155 patients). Because of these measured parameters, methylprednisolone should be considered a valuable adjunct to improving tissue perfusion during cardiopulmonary bypass.

This article has been cited by other articles:

				T. Sano, S. Morita, M. Masuda, and H. Yasui Minor Infection Encouraged by Steroid Administration During Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 505 - 510. [Abstract] [Full Text] [PDF]

				D. Shum-Tim, C. I. Tchervenkov, E. Laliberte, A.-M. Jamal, T. Nimeh, C.-Y. Luo, B. Bittira, and A. Philip Timing of steroid treatment is important for cerebral protection during cardiopulmonary bypass and circulatory arrest: minimal protection of pump prime methylprednisolone Eur. J. Cardiothorac. Surg., July 1, 2003; 24(1): 125 - 132. [Abstract] [Full Text] [PDF]

				V. A. Schroeder, J. M. Pearl, S. M. Schwartz, T. P. Shanley, P. B. Manning, and D. P. Nelson Combined Steroid Treatment for Congenital Heart Surgery Improves Oxygen Delivery and Reduces Postbypass Inflammatory Mediator Expression Circulation, June 10, 2003; 107(22): 2823 - 2828. [Abstract] [Full Text] [PDF]

				M. A. Chaney, R. A. Durazo-Arvizu, M. P. Nikolov, B. P. Blakeman, and M. Bakhos Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 561 - 569. [Abstract] [Full Text] [PDF]

				J.-P. Yared, N. J. Starr, F. K. Torres, C. A. Bashour, G. Bourdakos, M. Piedmonte, J. A. Michener, J. A. Davis, and T. E. Rosenberger Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery Ann. Thorac. Surg., May 1, 2000; 69(5): 1420 - 1424. [Abstract] [Full Text] [PDF]

				M. A. Chaney, M. P. Nikolov, B. P. Blakeman, M. Bakhos, and S. Slogoff Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation Ann. Thorac. Surg., April 1, 1999; 67(4): 1006 - 1011. [Abstract] [Full Text] [PDF]

				A. J. Lodge, P. J. Chai, C. W. Daggett, R. M. Ungerleider, and J. Jaggers METHYLPREDNISOLONE REDUCES THE INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS IN NEONATAL PIGLETS: TIMING OF DOSE IS IMPORTANT J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 515 - 522. [Abstract] [Full Text] [PDF]